Search results
Vertex Stock Hit All-Time High, Paused, Rising Again
Investor's Business Daily· 9 hours agoHighly rated Vertex Pharmaceuticals (VRTX) continues to trade near its all-time high. The upgraded Relative Strength Rating shows that Vertex stock tops...
Unveiling Vertex Pharmaceuticals (VRTX)'s Market Value: A Compre
Guru Focus· 12 hours agoVertex Pharmaceuticals Inc (VRTX, Financial) recently reported a daily loss of 1.32%, reflecting a slight dip in its stock price, yet it has gained 1.74% ...
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by StockNews.com
ETF DAILY NEWS· 4 days agoBarclays lifted their target price on Vertex Pharmaceuticals from $446.00 to $472.00 and gave the stock an “overweight” rating in a report on Tuesday, February ...
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
Zacks via Yahoo Finance· 14 hours agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its...
Simply Wall St. via Yahoo Finance· 6 days agoAs you might know, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) just kicked off its latest...
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy | The...
The Motley Fool· 2 days agoVertex Pharmaceuticals is making steady progress toward earning approval for a new CF medicine....
Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.
Forbes· 22 hours ago...Sovaldi in December 2013 directly causing Incivek’s commercial flameout, Jeff Leiden, M.D.,...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 7 days agoVertex Pharmaceuticals (NASDAQ:VRTX) First Quarter 2024 Results Key Financial Results Revenue:...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 7 days agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...